Indonesian Political, Business & Finance News

OpenAI acquires start-up to strengthen its biotechnology business

| Source: Antara (Indonesian) Translated from Indonesian | Business
OpenAI acquires start-up to strengthen its biotechnology business
Image: Antara (Indonesian)

Jakarta (ANTARA) – Artificial intelligence company OpenAI has made another acquisition, this time to strengthen its biotechnology business.

The start-up, Orchestra Bio, develops AI biotechnology software and is just four years old.

OpenAI announced the move on its website, as reported by TechCrunch on Tuesday (20 October), local time.

The details of the agreement between OpenAI and Orchestra Bio were not disclosed. However, the start-up reportedly raised around US$20 million (equivalent to Rp320 billion in 2025) from venture capital firms including Andreessen Horowitz, Atria and 8VC.

OpenAI said it would add Orchestra’s team and technology to work on Rosalind, its AI model for life sciences research, and associated tool Rosalind Workbench, a framework intended to help researchers plan experiments and analyse results.

OpenAI has secured several major pharmaceutical manufacturers as Rosalind customers, including, according to the company, Moderna and Novo Nordisk.

The acquisition is a classic example of how major AI laboratories such as OpenAI and Anthropic are continuing to build software for industries including pharmaceuticals.

In the start-up world, there is persistent concern that these laboratories could launch new features at any time and become competitors. In this case, Orchestra Bio was fortunate to be acquired rather than pushed out of the industry.

More from 21 October 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/openai-acquires-start-up-to-strengthen-its-biotechnology-business-1792576425)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5801909/openai-akuisisi-perusahaan-rintisan-untuk-perkuat-bisnis-bioteknologi), translated from Indonesian
Print